Presentations by Session

Emerging Discovery Strategies

An update on the JUMP-CP Consortium: insights from pilot experiments and outlook
Tue9 Nov11:15am(30 mins)			Paula A. Marin-Zapata
Session : Emerging Discovery Strategies Room: Auditorium

R&D at the New Speed of Science - Accelerate your R&D Transformation with Benchling
Tue9 Nov11:45am(5 mins)			Jonathan Stone
Session : Emerging Discovery Strategies Room: Auditorium

From Theraphosid to Therapy: Screening a venom library using high-throughput automated patch clamp to identify novel and selective sodium channel modulators
Tue9 Nov11:50am(30 mins)	Miss Elaine Duncan	Steven Trim
Session : Emerging Discovery Strategies Room: Auditorium

Fragment-based screening coupled to chemical proteomics as an emerging paradigm for early drug discovery in ER+ breast cancer
Tue9 Nov02:00pm(30 mins)	Dr Stephanie Constantinou	Dr Aarti Kawatkar
Session : Emerging Discovery Strategies Room: Auditorium

CDD Vault - Complexity Simplified
Tue9 Nov02:30pm(5 mins)			Miss Tamsin Lamont
Session : Emerging Discovery Strategies Room: Auditorium

The concept of G-quadruplex ligands as novel gene regulators and potential anticancer drugs
Tue9 Nov02:35pm(30 mins)			Stephen Neidle
Session : Emerging Discovery Strategies Room: Auditorium

Right assay, right hit, right time. Identify “more physiological hits” earlier in drug discovery
Tue9 Nov03:35pm(30 mins)			Mrs Kathy Dodgson
Session : Emerging Discovery Strategies Room: Auditorium

Patient-derived cell models as a clinically-relevant drug discovery strategy
Tue9 Nov04:05pm(30 mins)			Gareth Griffiths
Session : Emerging Discovery Strategies Room: Auditorium

Modernising Drug Design and Prioritisation with AI
Wed10 Nov10:30am(30 mins)			Simon Richards
Session : Emerging Discovery Strategies Room: Auditorium

Getting started with high-throughput mass spectrometry in early drug discovery
Wed10 Nov11:00am(30 mins)			Dr Martin Bachman
Session : Emerging Discovery Strategies Room: Auditorium

Development of BromoTag: A “Bump-and-Hole”–PROTAC System to Induce Potent, Rapid, and Selective Degradation of Tagged Target Proteins
Wed10 Nov11:30am(30 mins)			Adam Bond
Session : Emerging Discovery Strategies Room: Auditorium

Accelerating the validation of endogenous on-target engagement and assessment of in-cellulo kinetics for covalent inhibitors in early drug discovery
Wed10 Nov01:30pm(30 mins)			Dr Vasudev Kantae
Session : Emerging Discovery Strategies Room: Auditorium

New way of screening: A case study comparing an iterative screening approach to conventional HTS campaigns.
Wed10 Nov02:00pm(30 mins)			Markus Hierl
Session : Emerging Discovery Strategies Room: Auditorium

A MALDI-TOF assay identifies nilotinib as an inhibitor of inflammation in acute myeloid leukaemia
Wed10 Nov02:30pm(30 mins)			Prof Matthias Trost
Session : Emerging Discovery Strategies Room: Auditorium

Programme

Hosted By

ELRIG

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'

Privacy Notice